MedWatch

”We are slowly breaking through the magic barrier”

Lars Kongsbak, CEO in Exiqon, is highly satisfied with the first six months of the year. There is a good foundation for growth now, he says.

Foto: Exiqon/ PR

A swelling top and bottom line spurs enthusiasm from Lars Kongsbak. The top line growth of 23 % in H1 is mainly powered by PCR products, for which the company outperforms the general market. The top chief has no reservations about calling it the company’s most important product range.

“We continue the trend we have witnessed for the latest many, many quarters now, and we are slowly breaking through the magic barrier. It’s not the first quarterly statement showing a positive EBITDA, but we can see that there’s a good foundation now,” says Lars Kongsbak in an interview with Medwatch.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier